Actively Recruiting
AI-Driven Early Detection of Skin Cancer
Led by Nuvana Healthcare LTD · Updated on 2025-09-26
100
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
Sponsors
N
Nuvana Healthcare LTD
Lead Sponsor
N
National Institute for Health Research, United Kingdom
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.
CONDITIONS
Official Title
AI-Driven Early Detection of Skin Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (≥18 years) presenting with skin lesions suspicious for malignancy.
- Ability to provide informed consent.
You will not qualify if you...
- Inability to provide informed consent.
- Poor-quality images unsuitable for AI analysis.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nuvana Healthcare Ltd
London, United Kingdom
Actively Recruiting
Research Team
S
Sushma Saxena, Director, Nuvana Healthcare Ltd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here